Normal view MARC view ISBD view

Pharmaceutical industry : (Record no. 23166)

MARC details
000 -LEADER
fixed length control field	01890cam a2200265ua 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field	140604n nyu \|\|\|gr\|\|\|\|Z\|\|\|\|\|\|eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	9781612093949(hbk)
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number	615.19
Item number	MAN
245 ## - TITLE STATEMENT
Title	Pharmaceutical industry :
Remainder of title	innovation and developments /
Statement of responsibility, etc	David A. Mancuso and Isobel M. Grenada, editors.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc	Hauppauge, N.Y. :
Name of publisher, distributor, etc	Nova Science,
Date of publication, distribution, etc	2011..
300 ## - PHYSICAL DESCRIPTION
Extent	ix, 182 p. :
Dimensions	26 cm..
490 ## - SERIES STATEMENT
Series statement	Business issues, competition and entrpreeurship
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc	Includes bibliographical references index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note	Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA`s authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element	Drug development.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element	Pharmaceutical industry.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element	Drugs
General subdivision	Law and legislation.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element	Drug Industry
General subdivision	economics.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element	Drug Industry
General subdivision	legislation & jurisprudence.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element	Drug Discovery
General subdivision	economics.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element	Drugs, Generic
General subdivision	economics.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name	Mancuso, David A.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name	Grenada, Isobel M.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type	Books

Holdings
Withdrawn status	Lost status	Source of classification or shelving scheme	Damaged status	Not for loan	Home library	Current library	Shelving location	Date acquired	Total Checkouts	Total Renewals	Full call number	Barcode	Date last seen	Date checked out	Price effective from	Koha item type
		Dewey Decimal Classification			Central Library	Central Library	General Section	29/08/2014	1	1	615.19 MAN	019930	18/04/2016	17/03/2016	29/08/2014	Books